338 related articles for article (PubMed ID: 7880376)
1. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
[TBL] [Abstract][Full Text] [Related]
3. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
[TBL] [Abstract][Full Text] [Related]
4. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size.
Brooks N; McHugh PJ; Lee M; Hartley JA
Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
[TBL] [Abstract][Full Text] [Related]
6. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
7. Alkylation specificity for a series of distamycin analogues that tether chlorambucil.
Wyatt MD; Lee M; Hartley JA
Anticancer Drug Des; 1997 Jan; 12(1):49-60. PubMed ID: 9051113
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of benzoic acid mustard derivatives of imidazole-containing and C-terminal carboxamide analogues of distamycin.
Hartley JA; Preti CS; Wyatt MD; Lee M
Drug Des Discov; 1995 Apr; 12(4):323-35. PubMed ID: 9040992
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycin.
Lee M; Rhodes AL; Wyatt MD; D'Incalci M; Forrow S; Hartley JA
J Med Chem; 1993 Apr; 36(7):863-70. PubMed ID: 8464041
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship of a series of C-terminus modified aminoalkyl, diaminoalkyl- and anilino-containing analogues of the benzoic acid mustard distamycin derivative tallimustine: synthesis, DNA binding and cytotoxicity studies.
Brooks N; Hartley JA; Simpson JE; Wright SR; Woo S; Centioni S; Fontaine MD; McIntyre TE; Lee M
Bioorg Med Chem; 1997 Aug; 5(8):1497-507. PubMed ID: 9313856
[TBL] [Abstract][Full Text] [Related]
11. DNA binding properties of novel distamycin analogs that lack the leading amide unit at the N-terminus.
Bhattacharya S; Thomas M
Biochem Biophys Res Commun; 2000 Jan; 267(1):139-44. PubMed ID: 10623588
[TBL] [Abstract][Full Text] [Related]
12. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
Coley HM; Mongelli N; D'Incalci M
Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
[TBL] [Abstract][Full Text] [Related]
13. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
Atwell GJ; Fan JY; Tan K; Denny WA
J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
[TBL] [Abstract][Full Text] [Related]
14. Sequence-specific DNA alkylation of novel tallimustine derivatives.
Marchini S; Cozzi P; Beria I; Geroni C; Capolongo L; D'Incalci M; Broggini M
Anticancer Drug Des; 1998 Apr; 13(3):193-205. PubMed ID: 9595033
[TBL] [Abstract][Full Text] [Related]
15. The sequence specificity of alkylation for a series of benzoic acid mustard and imidazole-containing distamycin analogues: the importance of local sequence conformation.
Wyatt MD; Lee M; Hartley JA
Nucleic Acids Res; 1997 Jun; 25(12):2359-64. PubMed ID: 9171086
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biophysical evaluation of minor-groove binding C-terminus modified pyrrole and imidazole triamide analogs of distamycin.
Brown T; Taherbhai Z; Sexton J; Sutterfield A; Turlington M; Jones J; Stallings L; Stewart M; Buchmueller K; Mackay H; O'hare C; Kluza J; Nguyen B; Wilson D; Lee M; Hartley JA
Bioorg Med Chem; 2007 Jan; 15(1):474-83. PubMed ID: 17035029
[TBL] [Abstract][Full Text] [Related]
17. Selective DNA interaction of the novel distamycin derivative FCE 24517.
Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
[TBL] [Abstract][Full Text] [Related]
18. In vitro photoinduced cytotoxicity and DNA binding properties of psoralen and coumarin conjugates of netropsin analogues: DNA sequence-directed alkylation and cross-link formation.
Lee M; Roldan MC; Haskell MK; McAdam SR; Hartley JA
J Med Chem; 1994 Apr; 37(8):1208-13. PubMed ID: 8164263
[TBL] [Abstract][Full Text] [Related]
19. Unusual DNA binding exhibited by synthetic distamycin analogues lacking the N-terminal amide unit under high salt conditions.
Thomas M; Rao AR; Varshney U; Bhattacharya S
J Biomol Struct Dyn; 2001 Jun; 18(6):858-71. PubMed ID: 11444374
[TBL] [Abstract][Full Text] [Related]
20. Pyrazole analogues of the bispyrrolecarboxamide anti-tumour antibiotics: synthesis, DNA binding and anti-tumour properties.
Lee HH; Boyd M; Gravatt GL; Denny WA
Anticancer Drug Des; 1991 Nov; 6(5):501-17. PubMed ID: 1662514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
